LIBRE
Live / Registered — Registered (as of 10 Sept 2024)
What this means for you
Registered since 10 Sept 2024. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 88985182
- Registration number
- 7502551
- Mark type
- Stylized text
- Filed
- 20 May 2019
- Published for opposition
- 24 Mar 2020
- Registered
- 10 Sept 2024
- Attorney of record
- Michele H. Bowman
Goods and services
- Class 010 — Medical apparatus: Medical diagnostic apparatus for determination of analyte concentrations; medical apparatus for monitoring analyte concentrations in interstitial fluid; patient monitoring sensors for monitoring analyte concentrations; sensors for monitoring analyte concentrations for health purposes; patient monitoring sensors for determination of analyte concentrations in interstitial fluid; sensors for determination of analyte concentrations in interstitial fluid for health purposes; None of the foregoing in the field of personal emergency response systems (PERS) or mobile personal emergency response systems (MPERS) except in connection with management of diabetes
Owner
- Abbott Diabetes Care Inc., Alameda, CA, US
- Abbott Diabetes Care Inc., Alameda, CA, US
- Abbott Diabetes Care Inc., Alameda, CA, US
Prosecution history
- 10 Sept 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 10 Sept 2024 — REGISTERED-PRINCIPAL REGISTER
- 05 Aug 2024 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 05 Aug 2024 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 20 Jun 2024 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 20 Jun 2024 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 20 Jun 2024 — ASSIGNED TO LIE
- 05 Feb 2024 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 30 Oct 2023 — APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
- 30 Oct 2023 — APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
- 07 Aug 2023 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 07 Aug 2023 — NON-FINAL ACTION E-MAILED
- 07 Aug 2023 — SU - NON-FINAL ACTION - WRITTEN
- 28 Jun 2023 — STATEMENT OF USE PROCESSING COMPLETE
- 23 May 2023 — USE AMENDMENT FILED